Plus Therapeutics, Inc. (PSTV)
NASDAQ·Healthcare·Biotechnology
$3.86
—
Mkt Cap $14.49M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$25.00
Range $25.00 – $25.00
Implied Upside
+547.2%
Consensus $25.00 vs current $3.86
NASDAQ·Healthcare·Biotechnology
$3.86
—
Mkt Cap $14.49M
No recent rating data.
Price Target (2 analysts)
$25.00
Range $25.00 – $25.00
+547.2%
Consensus $25.00 vs current $3.86